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Results and discussion
is an excellent inverse correlation between the activation Activated and tyrosine-phosphorylated forms of c-Abl state and the stability of different c-Abl forms, in which are more unstable than inactive c-Abl proteins the active proteins that are tyrosine phosphorylated are To test whether activated c-Abl is downregulated through more unstable than the inactive ones. decreased protein stability, we compared the stability of constitutively activated forms of c-Abl to that of inactive c-Abl. We transfected c-Abl or constitutively activated
To examine whether activation of c-Abl by mechanisms hr, respectively) independent of tyrosine phosphorylation. To test whether the activated c-Abl proteins are downregulated by the 26S proteasome, we measured the half-life These results demonstrate that tyrosines 245 and 412 are important for activating and regulating the stability of c-Abl of activated c-Abl ⌬SH3 produced in vitro in the presence or absence of the 26S proteasome inhibitor MG132 [15, wild-type, but do not play a major role in protein stability once c-Abl has adopted the activated state (open confor -16] . The c-Abl ⌬SH3 protein was significantly more stable in the presence of MG132, with an average increase in mation) elicited by the P131L mutation. These findings are in agreement with previous reports showing that, while protein half-life of 3.4 Ϯ 0.9 hr over the control ( Figure  3b ). The stability of c-Abl ⌬SH3 in cells was also increased mutation of tyrosines 245 and 412 in c-Abl wild-type dramatically decreases c-Abl enzymatic activity in vitro, musignificantly after inhibition of the 26S proteasome by MG132. The half-life of c-Abl ⌬SH3 in the presence of tation of these tyrosines in c-Abl P131L only decreases specific activity by less than 2-fold [14] .
the solvent dimethyl sulphoxide (DMSO) was 8 Ϯ 3 hr, compared to 29 Ϯ 12 hr in the presence of MG132 ( Figure  3c ). Thus, activated c-Abl ⌬SH3 is downregulated by the
26S proteasome inhibition induces accumulation
26S proteasome in vitro and in vivo.
of tyrosine-phosphorylated c-Abl
A possible mechanism that may explain the differences in stability between activated and nonactivated c-Abl proIf tyrosine-phosphorylated c-Abl is regulated through the proteasome, then inhibition of the proteasome should teins is an increased susceptibility of activated Abl proteins to degradation through an ATP-dependent protein augment the levels of endogenous, tyrosine-phosphorylated c-Abl. To test this hypothesis, we used cells expressdegradation pathway. To test this possibility, ATP was substituted in the reaction with ATP␥S, a nonhydrolyzing activated v-Src, which produces high levels of activated c-Abl [6]. The 26S proteasome was inhibited with able ATP analog. The addition of ATP␥S increased the stability of c-Abl P131L (Figure 3a ) and c-Abl ⌬SH3 (data MG132 in the presence of cycloheximide to prevent the synthesis of new protein. A faint band corresponding to not shown) to levels that were similar to that of wildtype c-Abl (Figure 3a) . Thus, decreased stability of the tyrosine-phosphorylated c-Abl is detected in the absence of proteasome inhibition, which clearly increased after activated forms of c-Abl occurs through an ATP-dependent proteolytic pathway, such as that associated with the MG132 treatment (Figure 3d, upper panel) . The levels of total c-Abl also increased after MG132 treatment, as degradation by the 26S proteasome. expected (Figure 3d, middle panel) . In contrast, the levels A recent report showed that c-Abl can be dephosphorylated and inactivated by tyrosine-specific phosphatases of Erk protein (Figure 3d , bottom panel) and v-Src (data not shown) remained unchanged. Therefore, the differ- [21] . Our data suggest that tyrosine-phosphorylated c-Abl can undergo another type of inactivation: an irreversible ences in c-Abl tyrosine phosphorylation are not due to changes in the levels of v-Src. Significantly, we also dedownregulation by the 26S proteasome that would prevent deregulation of cellular processes involving signaling tected tyrosine phosphorylation of endogenous c-Abl after inhibition of the proteasome and after platelet-derived pathways downstream of activated c-Abl kinases. growth factor (PDFG) and pervanadate treatment in
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NIH-3T3 fibroblasts (Figure 3e) . Interestingly, the tyroSupplementary material including additional Materials and methods is sine-phosphorylated c-Abl pool is clearly increased after available at http://images.cellpress.com/supmat/supmatin.htm.
proteasome inhibition in the presence of PDGF and pervanadate (Figure 3e ). These observations suggest that
